• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Paw CBD Recognized With "Dog Hip & Joint Product Of The Year" Award From Pet Innovation

    8/17/23 8:00:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $YCBD alert in real time by email

    LOS ANGELES, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet Care industry, today announced that cbdMD, Inc. (NYSE:YCBD, YCBD PR A))), one of the leading and most highly trusted and recognized cannabidiol (CBD) brands, and its CBD pet products brand, Paw CBD, is the recipient of the "Dog Hip & Joint Product of the Year" award for their Hip+Joint Soft Chews in the 2023 awards program.

    Paw CBD Hip+Joint Soft Chews provide extra comfort and care for dogs in order to support mobility and enhance comfort. The company created these functional soft chews to maximize canine hip and joint health with proven ingredients including Glucosamine HCL and Chondroitin Sulfate to support mobility as well as Omega-3 Fatty Acids which may help ease inflammation.

    Paw CBD's NASC certified Hip+Joint Chews come in a bacon flavor, and the soft texture makes it ideal for small, aging, or sensitive teeth. The chews are available in three strengths based on a dog's weight: 150 mg, 300 mg, and 600 mg, which offer more precise serving options and optimal effectiveness.

    The CBD soft chews start with the company's clinically studied Superior Broad-Spectrum formula, made with only premium, US-grown hemp and then third-party lab tested to ensure purity. The chews are also veterinarian-formulated and crafted to be free of THC. As with all Paw CBD products for pets, the chews are produced avoiding unnecessary fillers or artificial ingredients.

    "A common reason dog parents turn to CBD products is the aim of supporting mobility, especially if they have overly active, large-breed, or aging canine companions. CBD alone is sought after for its powerful properties that enhance wellness, but we wanted to go beyond the basics to create our soft chews," said Ronan Kennedy, interim CEO of cbdMD. "We're so excited to be recognized with the ‘Dog Hip & Joint Product of the Year' award from Pet Innovation. This product was formulated specifically to make life better for dogs who need mobility support."

    The mission of the annual Pet Innovation Awards Program is to honor innovation and recognize excellence, hard work and success in a range of Pet Care industry categories, including Apparel, Grooming & Cleaning, Food & Treats, Health, Housing, Toys, Training, Retailers & Services and more. The 2023 Pet Innovation Awards attracted more than 2,000 nominations from around the world.

    "Activity, breed, or age-related discomfort can keep our faithful friends from enjoying everyday play, exercise, and even activities like jumping on the couch or into bed. When it comes to our beloved dogs, we want more walks, more play, and more cuddles. PawCBD offers a product that makes every day happy, healthy, and comfortable for pets," said Travis Grant, Managing Director, Independent Innovation Awards. "Whether for a canine companion experiencing a little stiffness or a breed that's prone to hip issues, these CBD hip and joint chews are the perfect option for the proper support of any dog's mobility."

    About The Pet Innovation Awards

    Part of Independent Innovation Awards organization, a global market intelligence and recognition program within the most competitive consumer categories, The Pet Innovation Awards honors the most outstanding and innovative companies, services, and products within the rapidly expanding pet care industry. The Pet Innovation Awards provides public recognition for achievements of pet care industry companies and products including Apparel, Grooming & Cleaning, Food & Treats, Health, Retailers & Services and more. For more information visit: https://petinnovationawards.com.

    About cbdMD, Inc.

    cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

    About Paw CBD

    Paw CBD is a nationally recognized pet consumer cannabidiol (CBD) brand, offering 40+ pet consumer products that combine the properties of CBD oil with "animal-approved" flavors like peanut butter, bacon, and turkey. Paw CBD is one of the fastest growing brands in the pet CBD space and is proud to have partnered in the past with Instagram celebrities, such as Nala Cat and the late Lil Bub. To learn more about the comprehensive line of THC-free[1] Paw CBD pet products, please visit PawCBD.com or follow Paw CBD on Instagram and Facebook.

    Travis Grant

    Pet Innovation Awards

    [email protected]

    949.667.4475



    Primary Logo

    Get the next $YCBD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $YCBD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YCBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a

    2/17/26 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

    CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.

    2/12/26 5:31:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum

    CHARLOTTE, N.C., Feb. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading innovator in wellness and hemp-derived consumer products, today announced a major distribution expansion for its Herbal Oasis THC-infused social seltzer ("Oasis") through an expanded partnership with Morales Beverage Group ("MBG"). The agreement extends Oasis into Louisiana, strengthening the brand's regional footprint across the Gulf South and creating a more contiguous platform for continued Southeast growth, following strong early performance in Texas. With MBG's established statewide distribut

    2/2/26 9:00:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    SEC Filings

    View All

    SEC Form EFFECT filed by cbdMD Inc.

    EFFECT - cbdMD, Inc. (0001644903) (Filer)

    3/5/26 12:15:15 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 424B4 filed by cbdMD Inc.

    424B4 - cbdMD, Inc. (0001644903) (Filer)

    3/4/26 5:24:35 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-Q filed by cbdMD Inc.

    10-Q - cbdMD, Inc. (0001644903) (Filer)

    2/17/26 4:06:16 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald resumed coverage on cbdMD with a new price target

    Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously

    6/18/21 6:26:36 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Cantor Fitzgerald reiterated coverage on cbdMD with a new price target

    Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously

    1/29/21 4:54:10 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Crosnoe Clark R. sold $1,276,842 worth of shares (550,701 units at $2.32) (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    12/19/25 9:16:26 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    CEO and CFO Kennedy Thomas Ronan was granted 445,000 shares, increasing direct ownership by 648% to 513,722 units (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    12/2/25 6:29:31 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    5/20/25 5:23:40 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Financials

    Live finance-specific insights

    View All

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a

    2/17/26 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

    CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.

    2/12/26 5:31:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance

    CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025. For fiscal year 2025, cbdMD delivered its third consecutive year of operational and financial improvement, reflecting disciplined cost management, focused execution, and continued investment in quality and science. The Company

    12/19/25 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

    8/12/22 4:02:14 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

    6/21/22 7:52:33 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

    5/19/22 4:05:28 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Leadership Updates

    Live Leadership Updates

    View All

    cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

    Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp

    4/10/25 5:57:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

    Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi

    6/22/23 9:00:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Welcomes Shannon Charles as Chief Marketing Officer

    Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h

    1/11/23 12:33:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary